| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2013 | CN101743005B Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 06/12/2013 | CN101715437B Stereoisomers propofol therapeutic compounds |
| 06/12/2013 | CN101684106B Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 06/12/2013 | CN101679315B Piperazine salts as d3/d2 antagonists |
| 06/12/2013 | CN101678031B Formulations containing triazinones and iron |
| 06/12/2013 | CN101674834B Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN101668736B Amidation process for the preparation of cathepsin k inhibitors |
| 06/12/2013 | CN101657453B Purines as PKC-theta inhibitors |
| 06/12/2013 | CN101646427B Akt活性抑制剂 Akt activity inhibitor |
| 06/12/2013 | CN101641089B An extract |
| 06/12/2013 | CN101636390B Napadisylate salt of a muscarinic M3 antagonist |
| 06/12/2013 | CN101605794B Aza-benzofuranyl compounds and methods of use |
| 06/12/2013 | CN101600719B Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101594861B Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/12/2013 | CN101573333B Inhibitors of histone deacetylase |
| 06/12/2013 | CN101554368B Tetrodotoxin composition formulation stable at room temperature and used for injection |
| 06/12/2013 | CN101522664B Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| 06/12/2013 | CN101522631B Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 06/12/2013 | CN101522623B Non-flushing niacin analogues, and methods of use thereof |
| 06/12/2013 | CN101507749B Medicine composition for curing the cerebrovascular disease |
| 06/12/2013 | CN101490040B 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 06/12/2013 | CN101490015B 瑞舒伐他汀锌盐 Rosuvastatin zinc |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/12/2013 | CN101479274B Pharmaceutical compounds |
| 06/12/2013 | CN101472577B Infusion preparation for dialysis patient |
| 06/12/2013 | CN101429184B Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 06/12/2013 | CN101415414B Use of citrulline for preparing drug for treating and correcting arginine lack in sepsis patient |
| 06/12/2013 | CN101410370B Selective hydroxamate based MMP inhibitors |
| 06/12/2013 | CN101361757B Combination containing brown alga polysaccharide sulfuric ester and propolis and use thereof |
| 06/12/2013 | CN101352433B Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 06/12/2013 | CN101282645B 改良的抗真菌组合物 Improved antifungal composition |
| 06/12/2013 | CN101280025B Antitumaous echinus shell polysaccharide and preparation thereof |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/12/2013 | CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 06/12/2013 | CN101208311B Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/12/2013 | CN101146816B Glycolipids of branched chain alkyl oligosaccharides for liquid crystal and related applications |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461410 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 06/11/2013 | US8461389 Psycho-pharmaceuticals |
| 06/11/2013 | US8461364 Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy)-3H-benzo[C][1,2]oxaborol-1-OL |
| 06/11/2013 | US8461362 Protein phosphatase 2A-activating agents |
| 06/11/2013 | US8461348 Heterocyclic derivative and use thereof |
| 06/11/2013 | US8461344 Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropdxypyridin)yl]-4-penten-2-amine |
| 06/11/2013 | US8461341 Resolution of (±)-methyl phenyl[4-[4-[[[4′(trifluoromethyl)-2-biphenylyl]carbonyl]amino]Phenyl]-1-piperidinyl]acetate |
| 06/11/2013 | US8461337 Sinomenine derivatives and processes for their synthesis |
| 06/11/2013 | US8461336 Boron-containing small molecules |
| 06/11/2013 | US8461333 Salts of prodrugs of piperazine and substituted piperidine antiviral agents |
| 06/11/2013 | US8461331 Method for the production of 3,6-dihydro-L, 3, 5-triazine derivatives from metformin and paraldehyde derivatives |
| 06/11/2013 | US8461330 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461224 Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461211 Use for budesonide and formoterol |
| 06/11/2013 | US8461210 Fast release paracetamol tablets |
| 06/11/2013 | US8461209 Malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 06/11/2013 | US8461208 Bis(thio-hydrazide amide) salts for treatment of cancers |
| 06/11/2013 | US8461207 Phloroglucinol derivatives having selectin ligand activity |
| 06/11/2013 | US8461206 Use of at least one (dihydro)jasmonic acid derivative for treating dry skin |
| 06/11/2013 | US8461205 Anthranilic acid derivatives |
| 06/11/2013 | US8461204 Cysteinyl compounds, compositions and methods of use |
| 06/11/2013 | US8461203 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/11/2013 | US8461200 Salicylic acid esters of resveratrol and cosmetic compositions |
| 06/11/2013 | US8461199 Transition metal complexes of a bis[thio-hydrazide amide] compound |
| 06/11/2013 | US8461198 Use of acacetin and related compounds as potassium channel inhibitors |
| 06/11/2013 | US8461197 4-hydroxybutyric acid analogs |
| 06/11/2013 | US8461196 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| 06/11/2013 | US8461195 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/11/2013 | US8461194 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40 |
| 06/11/2013 | US8461193 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 06/11/2013 | US8461192 Method of selectively inhibiting PKCiota |
| 06/11/2013 | US8461191 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 06/11/2013 | US8461190 Process for the purification of rufinamide |
| 06/11/2013 | US8461189 Pyridyl derivatives as histone deacetylase inhibitors |
| 06/11/2013 | US8461188 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 06/11/2013 | US8461186 Use of N-piperidine derivatives for the treatment of neurodegenerative pathologies |
| 06/11/2013 | US8461185 P2X3 receptor antagonists for treatment of pain |
| 06/11/2013 | US8461184 Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists |
| 06/11/2013 | US8461183 PPAR agonist compounds, preparation and uses |
| 06/11/2013 | US8461182 7-piperidinoalkyl-3, 4-Dihydroquinolone derivative |
| 06/11/2013 | US8461180 Inhibitors of human immunodeficiency virus replication |
| 06/11/2013 | US8461179 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| 06/11/2013 | US8461178 Naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/11/2013 | US8461177 Antiviral drugs for treatment of arenavirus infection |
| 06/11/2013 | US8461176 Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| 06/11/2013 | US8461175 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof |
| 06/11/2013 | US8461174 Treatment for cutaneous metastases |
| 06/11/2013 | US8461173 Rapid release mini-tablets provide analgesia in laboratory animals |
| 06/11/2013 | US8461172 Solid forms and process for preparing |
| 06/11/2013 | US8461171 Hybrid opioid compounds and compositions |
| 06/11/2013 | US8461170 Chemical compounds |
| 06/11/2013 | US8461169 Compounds modulating c-fms and/or c-kit activity |
| 06/11/2013 | US8461168 Process for the preparation of pyrimidine derivatives |
| 06/11/2013 | US8461167 Acetylenic heteroaryl compounds |
| 06/11/2013 | US8461166 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 06/11/2013 | US8461165 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 06/11/2013 | US8461164 Pteridines and their use as agrochemicals |
| 06/11/2013 | US8461163 Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1 |
| 06/11/2013 | US8461162 Pyrazolo[1,5-a]pyrimidine derivatives |